The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions

Journal of Neurology

Volumn 263, Issue 1, 2016, Pages 68-75

  Lewis, Mechelle M ^a   Du, Guangwei ^a   Lee, Eun Young ^a   Nasralah, Zeinab ^a   Sterling, Nicholas W ^a   Zhang, Lijun ^a   Wagner, Daymond ^a   Kong, Lan ^a   Tröster, Alexander I ^b   Styner, Martin ^c,d   Eslinger, Paul J ^a   Mailman, Richard B ^a   Huang, Xuemei ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Brain atrophy; MRI; Parkinson s disease; Volume

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN SIZE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SUBCORTEX; ATROPHY; DISEASE COURSE; FOLLOW UP; PATHOLOGY;

AGED; ATROPHY; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 84955742421     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7929-7     Document Type: Article

References (37)

1. Braak H, Del Tredici K, Rub U, de Vos RA, Steur ENJ, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211
2. Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ et al (2012) Grey matter atrophy in cognitively impaired Parkinson’s disease. J Neurol Neurosurg Psychiatry 83(2):188–194
3. Martin WR, Wieler M, Gee M, Camicioli R (2009) Temporal lobe changes in early, untreated Parkinson’s disease. Mov Disord 24(13):1949–1954
4. Gerrits NJ, van der Werf YD, Hofman M, Foncke EM, Klein M, Berendse HW et al (2014) Gray matter differences contribute to variation in cognitive performance in Parkinson’s disease. Eur J Neurol 21(2):245–252
5. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ (2001) Correlating rates of cerebral atrophy in Parkinson’s disease with measures of cognitive decline. J Neural Transm 108(5):571–580
6. Ibarretxe-Bilbao N, Junque C, Segura B, Baggio HC, Marti MJ, Valldeoriola F et al (2012) Progression of cortical thinning in early Parkinson’s disease. Mov Disord 27(14):1746–1753
7. Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ et al (2015) Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study. Brain 138(Pt 10):2974–2986
8. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 129(Pt 4):1040–1049
9. Camicioli R, Sabino J, Gee M, Bouchard T, Fisher N, Hanstock C et al (2011) Ventricular dilatation and brain atrophy in patients with Parkinson’s disease with incipient dementia. Mov Disord 26(8):1443–1450
10. Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283–2301
11. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20(4):415–455
12. Schulzer M, Lee CS, Mak EK, Vingerhoets FJ, Calne DB (1994) A mathematical model of pathogenesis in idiopathic parkinsonism. Brain 117(Pt 3):509–516
13. Halliday GM, McCann H (2010) The progression of pathology in Parkinson’s disease. Ann N Y Acad Sci 1184:188–195
14. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33–39
15. Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32(3):489–502
16. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
17. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170
18. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T et al (1992) Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7(1):2–13
19. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653
20. Ruigrok AN, Salimi-Khorshidi G, Lai MC, Baron-Cohen S, Lombardo MV, Tait RJ et al (2014) A meta-analysis of sex differences in human brain structure. Neurosci Biobehav Rev 39:34–50
21. Du G, Lewis MM, Sen S, Wang J, Shaffer ML, Styner M et al (2012) Imaging nigral pathology and clinical progression in Parkinson’s disease. Mov Disord 27(13):1636–1643
22. Rosenberg-Katz K, Herman T, Jacob Y, Giladi N, Hendler T, Hausdorff JM (2013) Gray matter atrophy distinguishes between Parkinson disease motor subtypes. Neurology 80(16):1476–1484
23. Fioravanti V, Benuzzi F, Codeluppi L, Contardi S, Cavallieri F, Nichelli P et al (2015) MRI correlates of Parkinson’s disease progression: a voxel based morphometry study. Parkinsons Dis 2015:378032
24. Weintraub D, Dietz N, Duda JE, Wolk D, Doshi J, Xie SX et al (2012) Alzheimer’s disease pattern of brain atrophy predicts cognitive decline in Parkinson’s disease. Brain J Neurol 135(Pt 1):170–180
25. Kato S, Watanabe H, Senda J, Hirayama M, Ito M, Atsuta N et al (2012) Widespread cortical and subcortical brain atrophy in Parkinson’s disease with excessive daytime sleepiness. J Neurol 259(2):318–326
26. Hanganu A, Bedetti C, Degroot C, Mejia-Constain B, Lafontaine AL, Soland V et al (2014) Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson’s disease longitudinally. Brain 137(Pt 4):1120–1129
27. Lee EY, Eslinger PJ, Du G, Kong L, Lewis MM, Huang X (2014) Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson’s disease. Mov Disord 29(9):1205–1208
28. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381
29. Peran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, et al (2010) Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain 33(11):3423–3433
30. Middleton FA, Strick PL (2000) Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev 31(2–3):236–250
31. Lee CS, Schulzer M, Mak EK, Snow BJ, Tsui JK, Calne S et al (1994) Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 117(Pt 3):501–507
32. Rossi C, Frosini D, Volterrani D, De FP, Unti E, Nicoletti V et al (2010) Differences in nigro-striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP-CIT SPECT study. Eur J Neurol 17(4):626–630
33. Maetzler W, Liepelt I, Berg D (2009) Progression of Parkinson’s disease in the clinical phase: potential markers. Lancet Neurol 8(12):1158–1171
34. Perlmutter JS, Norris SA (2014) Neuroimaging biomarkers for Parkinson disease: facts and fantasy. Ann Neurol 76(6):769–783
35. Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL (2003) Limitations of current Parkinson’s disease therapy. Ann Neurol 53(Suppl 3):S3–S12
36. Lee CS, Schulzer M, Mak EK, Snow BJ, Tsui JK, Calne S et al (1994) Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 117(Pt 3):501–507
37. Lee CS, Schulzer M, Fuente-Fernandez R, Mak E, Kuramoto L, Sossi V et al (2004) Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Arch Neurol 61(12):1920–1925